Fisher Asset Management
CADL icon

Fisher Asset Management’s Candel Therapeutics CADL Stock Holding History

Fisher Asset Management’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Buy
+57,800
New +$437K ﹤0.01% 778

Other funds holding CADL

HFF
Halter Ferguson Financial Carmel, Indiana $617M AUM 69.99% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
TGIA
Torrey Growth & Income Advisors Del Mar, California $294M AUM 37.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Fisher Asset Management's CADL Position: Q2 2026 in Review

Fisher Asset Management opened a new position in Candel Therapeutics (CADL) in Q2 2026: 57,800 shares worth $595K. The stake represents ﹤0.01% of the portfolio and ranks #778 among its holdings.

30 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Fisher Asset Management held 57,800 shares of Candel Therapeutics worth $595K as of Q2 2026.
  • Candel Therapeutics was a new Fisher Asset Management position in Q2 2026.
  • Candel Therapeutics made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #778 holding.
  • 30 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.